AMINEX THERAPEUTICS INC has a total of 14 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are QUANTUM GENOMICS, NEUROQUEST INC and CHANG RICHARD L.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EAPO (Eurasian Patent Organization) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Burns Mark R | 11 |
#2 | O'Brien Thomas G | 1 |
#3 | Burns Mark Robert | 1 |
#4 | Gilmour Susan K | 1 |
#5 | Baindur Nand | 1 |
#6 | Graminski Gerard F | 1 |
#7 | Mark R Burns | 1 |
Publication | Filing date | Title |
---|---|---|
KR20180123133A | The bioavailable polyamines | |
US2011256161A1 | Methods for enhancing immune response |